Pasteurella Pneumonia

Pasteurella pneumonia is a significant bacterial respiratory disease of cattle caused primarily by Pasteurella multocida. This opportunistic pathogen forms an important component of the Bovine Respiratory Disease Complex (BRDC), frequently causing secondary bacterial pneumonia following viral respiratory infections or stress-induced immunosuppression. While often overshadowed by the more aggressive Mannheimia haemolytica, Pasteurella multocida causes substantial morbidity and mortality in cattle populations worldwide, particularly in young calves and feedlot animals.

Pasteurella multocida affects cattle of all ages and production types, though disease patterns vary across different populations. Young dairy calves housed in group settings commonly develop pasteurella pneumonia during respiratory disease outbreaks. Feedlot cattle, particularly during the high-risk receiving period, experience pneumonia caused by Pasteurella multocida alone or in combination with other bacterial pathogens. The organism is ubiquitous in cattle populations, residing as a normal inhabitant of the upper respiratory tract in many healthy animals, only causing disease when host defenses become compromised.

The economic impact of Pasteurella pneumonia contributes significantly to the overall billion-dollar burden of bovine respiratory disease on the cattle industry. Treatment costs, mortality losses, reduced growth performance, decreased feed efficiency, and prolonged time to market all contribute to economic losses. While individual cases may be less severe than those caused by Mannheimia haemolytica, the high prevalence of Pasteurella involvement in respiratory disease outbreaks makes it an important economic consideration for cattle producers. Additionally, chronic pneumonia cases that fail to fully resolve impact animal welfare and long-term productivity.

Treatment of Pasteurella pneumonia with appropriate antimicrobials is generally effective when initiated early in the disease course, distinguishing it from some other respiratory pathogens with poorer treatment responses. The key to successful management lies in rapid case identification and prompt treatment initiation before extensive lung damage occurs. Comprehensive prevention programs incorporating vaccination, stress reduction, and biosecurity measures help reduce disease incidence and severity across susceptible cattle populations.

Pasteurella multocida is a gram-negative coccobacillus bacterium that serves as the primary etiologic agent of pasteurella pneumonia in cattle. This organism belongs to the Pasteurellaceae family along with Mannheimia haemolytica and other related respiratory pathogens. Multiple serotypes exist based on capsular polysaccharide composition, with type A strains most commonly associated with bovine respiratory disease. The organism produces various virulence factors including capsular polysaccharide that inhibits phagocytosis, adhesins that facilitate attachment to respiratory epithelium, and toxins that contribute to tissue damage and immune evasion.

No specific genetic predisposition to Pasteurella pneumonia has been identified in cattle, though general genetic variation in immune function likely influences individual susceptibility and disease severity. All cattle breeds can become infected when exposed under appropriate predisposing conditions. Individual animals may demonstrate varying levels of resistance based on immune competence, previous exposure, vaccination status, and overall health. The organism's role as an opportunistic pathogen means that management and environmental factors typically exert greater influence on disease occurrence than host genetics.

Environmental and management factors play crucial roles in the development of pasteurella pneumonia. Poor ventilation leading to accumulation of ammonia, dust, and airborne pathogens irritates respiratory mucosa and impairs natural defenses. Temperature extremes, particularly cold stress or heat stress, increase susceptibility to respiratory disease. Overcrowding increases pathogen exposure while creating social stress. Transport, weaning, commingling, and dietary changes create physiological stress that compromises immune function. Dirty, damp bedding and contaminated feeding equipment increase pathogen exposure.

Risk factors for Pasteurella pneumonia include many conditions common to the broader respiratory disease complex. Young age, particularly calves between two weeks and six months old, represents a high-risk period when maternal immunity wanes before adequate active immunity develops. Recent stress events including transport, weaning, processing, and environmental changes increase disease risk. Concurrent viral infections, particularly with IBR, BVDV, BRSV, and PI3, damage respiratory epithelium and suppress immune responses, creating conditions favorable for bacterial proliferation. Nutritional deficiencies, parasitism, and concurrent diseases further increase susceptibility.

The pathophysiology of Pasteurella pneumonia involves colonization and invasion of lower respiratory tissues compromised by prior insult. Under normal conditions, mucociliary clearance, alveolar macrophages, and other innate defenses prevent bacterial proliferation in the lungs. When viral infection, stress, or environmental factors impair these defenses, Pasteurella multocida descends from the upper respiratory tract and establishes infection in lung tissue. The organism's capsule resists phagocytosis, allowing bacterial multiplication. Inflammatory responses attempting to clear infection cause tissue damage, exudate accumulation, and the consolidation characteristic of bacterial pneumonia. Unlike Mannheimia haemolytica, Pasteurella multocida does not produce leukotoxin, generally resulting in less severe acute inflammation but potentially more chronic disease progression.

Early warning signs of Pasteurella pneumonia may be subtle and easily missed without careful observation. Initial symptoms often include mild depression, slightly reduced feed intake, and occasional coughing that could be attributed to minor respiratory irritation. Body temperature becomes elevated, though often not to the extreme levels seen with Mannheimia haemolytica, typically ranging from 103 to 105 degrees Fahrenheit in early disease. Animals may appear slightly dull or separate themselves from group mates. Recognition of these early signs enables intervention before disease progression to more serious stages.

Common symptoms of established Pasteurella pneumonia reflect lower respiratory tract infection and systemic illness. Moderate to marked depression develops as disease progresses, with affected animals showing drooping ears, dull eyes, and obvious lethargy. Anorexia progresses from reduced intake to complete feed refusal in more severely affected cases. Respiratory rate increases, and animals may show mild to moderate dyspnea with increased abdominal effort during breathing. Nasal discharge typically progresses from serous to mucopurulent as disease advances and secondary bacterial involvement increases.

Behavioral changes in cattle with Pasteurella pneumonia provide important clues for early case identification. Affected animals tend to lag behind group mates when moved and show reluctance to engage in normal activities. They may spend more time lying down and be slow to rise when approached. Appetite changes are often among the first behavioral indicators, with sick animals showing reduced interest in feed or failing to compete effectively at feed bunks. Isolation from the group and decreased social interaction characterize illness behavior that reflects systemic inflammation and malaise.

Physical signs of Pasteurella pneumonia include findings consistent with lower respiratory infection upon examination. Respiratory rate is elevated, often exceeding 40 breaths per minute in affected adults. Auscultation of the thorax reveals increased breath sounds, crackles, and wheezes in affected lung regions, with areas of consolidation showing reduced or absent air movement. Coughing may be spontaneous or easily induced by tracheal pressure. The muzzle may be dry and crusted with mucopurulent discharge. Hydration status often reflects reduced water intake during illness. Body condition may decline rapidly in acute cases or more gradually in animals with chronic disease.

Symptom progression in Pasteurella pneumonia varies based on host factors, pathogen virulence, and co-infections. In uncomplicated cases with prompt treatment, clinical signs may plateau and begin resolving within 24 to 48 hours. However, untreated cases or those with significant viral co-infection may progress to severe pneumonia with extensive lung involvement. Respiratory distress intensifies as consolidation increases, with animals showing extended head and neck posture and increased effort on both inspiration and expiration. Secondary complications including pleuritis, pericarditis, or systemic spread may develop in severe cases.

Emergency symptoms requiring immediate veterinary intervention include severe respiratory distress with labored breathing, open-mouth breathing, or cyanosis of mucous membranes indicating oxygen deprivation. Recumbent animals unable or unwilling to rise present a medical emergency. High fever exceeding 106 degrees Fahrenheit suggests severe infection or concurrent disease requiring urgent assessment. Animals showing rapid deterioration despite appropriate treatment may have developed complications or face overwhelming infection requiring treatment intensification or humane euthanasia consideration. Any suspected respiratory disease outbreak with multiple affected animals warrants immediate veterinary consultation for diagnostic workup and treatment protocol development.

Clinical examination for Pasteurella pneumonia follows standard approaches for bovine respiratory disease evaluation. Veterinary assessment includes measurement of rectal temperature, evaluation of respiratory rate and character, and thorough auscultation of all lung fields to characterize the extent and nature of pulmonary involvement. Physical examination evaluates overall body condition, hydration status, and presence of concurrent problems. Historical information regarding recent stress events, vaccination status, and disease patterns in herdmates provides important diagnostic context. Clinical scoring systems help standardize case identification and guide treatment decisions.

Diagnostic testing to identify Pasteurella multocida involvement employs several laboratory approaches. Transtracheal wash or bronchoalveolar lavage provides samples from the lower respiratory tract suitable for bacterial culture and antimicrobial sensitivity testing. Deep nasopharyngeal swabs offer a less invasive sampling alternative but may detect upper respiratory flora rather than the causative agent of pneumonia. Bacterial culture with identification confirms Pasteurella involvement and enables susceptibility testing to guide antimicrobial selection. PCR-based diagnostics provide rapid pathogen identification from clinical samples. Necropsy examination with lung tissue culture remains the most definitive diagnostic approach for fatal cases.

Differential diagnosis for Pasteurella pneumonia includes other bacterial and viral causes of bovine respiratory disease. Mannheimia haemolytica typically causes more severe acute disease with marked fibrinous inflammation, though clinical differentiation may be difficult without laboratory testing. Histophilus somni pneumonia may be accompanied by other systemic manifestations. Mycoplasma bovis causes chronic pneumonia with poor treatment response. Viral respiratory pathogens including IBR, BVDV, BRSV, and PI3 may cause primary disease or predispose to secondary bacterial infection. Aspiration pneumonia occurs in the cranioventral lung regions and often has history of recent oral medication. Lungworm infection and other parasitic pneumonias require consideration in pastured cattle.

Herd-level diagnostics support effective outbreak management and guide prevention program development. When multiple animals develop respiratory disease, comprehensive diagnostic investigation should sample both clinically affected and apparently healthy in-contact animals to characterize the pathogen population. Culture and sensitivity testing from multiple cases identifies consistent bacterial involvement and potential antimicrobial resistance patterns that inform treatment protocols. Paired serology or PCR testing for viral respiratory pathogens helps identify primary infections predisposing to bacterial disease. Necropsy examination of animals that die or require euthanasia provides valuable information about disease processes and should be performed systematically during respiratory disease outbreaks.

Emergency and immediate treatment for cattle with severe Pasteurella pneumonia prioritizes rapid initiation of antimicrobial therapy and supportive care to stabilize critically ill animals. Severe respiratory distress cases require immediate veterinary assessment to determine appropriate treatment intensity and prognosis. Handling should be minimized to reduce stress on compromised respiratory systems. Emergency supportive measures include ensuring access to clean water, providing shelter from environmental extremes, and positioning recumbent animals to optimize breathing. Timely intervention significantly impacts outcomes, as delays allow disease progression and lung damage.

Medical management centers on appropriate antimicrobial selection based on known or expected susceptibility patterns. Pasteurella multocida generally shows good susceptibility to a range of antimicrobial classes, providing multiple treatment options. Macrolides including tulathromycin, gamithromycin, and tilmicosin represent common choices for respiratory disease treatment. Fluoroquinolones such as enrofloxacin provide excellent gram-negative coverage. Florfenicol, ceftiofur, and other cephalosporins offer additional options. Tetracyclines including oxytetracycline have activity against Pasteurella. Antimicrobial selection should consider regional resistance patterns, withdrawal time requirements for animals approaching market, and veterinary guidance. All medication use must comply with regulatory requirements and food safety standards.

Surgical intervention is not applicable to Pasteurella pneumonia treatment, as the condition involves diffuse lung parenchymal infection requiring medical rather than surgical management. Unlike localized infections amenable to surgical drainage, pneumonia affects tissues throughout affected lung lobes in patterns not suitable for surgical intervention. Focus remains entirely on antimicrobial therapy and supportive medical care. In rare chronic cases with localized abscessation, drainage might theoretically be considered but is rarely practical in cattle.

Supportive care complements antimicrobial therapy and significantly influences treatment outcomes. Non-steroidal anti-inflammatory drugs including flunixin meglumine or meloxicam reduce fever, decrease pulmonary inflammation, and improve comfort, encouraging return of appetite and activity. Fluid therapy addresses dehydration in animals that have not maintained adequate water intake during illness. Housing affected animals in clean, well-bedded areas with good ventilation facilitates recovery. Reducing social stress by separating sick animals from aggressive penmates while maintaining visual contact with the herd supports psychological wellbeing. Easy access to palatable feed and fresh water encourages intake as animals begin recovering.

Herd treatment protocols may be appropriate when respiratory disease outbreaks affect multiple animals simultaneously. Mass medication of high-risk groups through feed or water can provide baseline treatment coverage, though individual case identification and treatment remains important for severely affected animals. Metaphylactic antimicrobial treatment of all animals in high-risk groups upon arrival or at outbreak onset has demonstrated effectiveness in reducing disease incidence and severity. These approaches require veterinary guidance regarding product selection, timing, and appropriate target populations.

Treatment decisions for Pasteurella pneumonia consider multiple factors including disease severity, treatment history, economic value, and prognosis. Initial treatment success rates for appropriately managed cases generally range from 70 to 85 percent. Animals failing to respond to first treatment may require second-line therapy with alternative antimicrobial classes. Repeated treatment failures suggest complications, co-infections, or antimicrobial resistance requiring diagnostic investigation. Chronic cases with persistent illness despite treatment may warrant salvage slaughter if withdrawal times can be met, or humane euthanasia for animals that cannot be marketed. Economic analysis should guide decisions while maintaining animal welfare as a primary consideration.

Recovery timeline for Pasteurella pneumonia varies based on initial disease severity, treatment timing, and presence of complicating factors. Animals identified early and treated promptly typically show clinical improvement within 24 to 48 hours of antimicrobial administration. Fever usually resolves within 12 to 24 hours of effective treatment. Appetite and activity gradually return over the following two to four days. Complete clinical recovery in successfully treated uncomplicated cases generally occurs within one to two weeks, though lung healing continues for several additional weeks. Severe cases and those with complications require extended recovery periods.

Post-treatment care and monitoring ensures complete recovery and identifies animals requiring additional intervention. Treated cattle should be observed at least twice daily during the first week following treatment, evaluating temperature, appetite, respiratory effort, and general demeanor. Animals showing inadequate response within 48 to 72 hours require veterinary reassessment for potential treatment failure, complications, or need for alternative therapy. Following apparent clinical recovery, continued monitoring for two to three additional weeks helps identify relapse cases or development of chronic problems. Documentation of treatment dates, products, doses, and outcomes supports both herd health management and food safety compliance.

Prognosis factors in Pasteurella pneumonia include disease severity at diagnosis, timing of treatment initiation, presence of co-infections, extent of lung involvement, and individual animal health status. Cattle identified and treated during early disease stages with uncomplicated infection carry good prognosis for full recovery. Delayed treatment allowing extensive lung consolidation results in poorer outcomes regardless of antimicrobial efficacy. Concurrent infections with Mannheimia haemolytica, Histophilus somni, or viral pathogens complicate recovery. Young calves with immature immune systems and debilitated animals face higher mortality risk and more prolonged recovery periods.

Return to production considerations address performance impacts of respiratory disease recovery. Even clinically recovered cattle often demonstrate reduced growth rates and feed efficiency compared to animals that never developed disease. Research consistently shows that cattle treated for respiratory disease gain less weight per day and may require additional time on feed to reach target weights. Chronic lung damage from severe cases permanently impairs respiratory function and limits performance potential. Production records should track individual animal performance following respiratory disease to inform culling decisions and evaluate overall treatment economics.

Vaccination protocols for Pasteurella multocida prevention include multivalent respiratory disease vaccines that combine Pasteurella with other bacterial and viral pathogens. Most commercial respiratory vaccines incorporate killed Pasteurella multocida bacterins along with Mannheimia haemolytica components. Modified live viral vaccines containing IBR, BVDV, BRSV, and PI3 address the viral infections that commonly predispose to bacterial pneumonia. Vaccination timing should allow adequate immune response development before anticipated risk periods, typically requiring initial vaccination at least two to three weeks before weaning, transport, or feedlot entry. Booster vaccinations maintain immunity and are typically administered at processing following arrival.

Biosecurity measures help prevent introduction and spread of respiratory pathogens within cattle populations. While Pasteurella multocida is ubiquitous and cannot be eliminated from cattle populations, minimizing exposure to novel strains and pathogen loads reduces disease pressure. Avoiding commingling of cattle from multiple sources limits exposure to unfamiliar bacterial populations. Quarantine of new arrivals provides time for observation and recovery from transport stress before mixing with established animals. Controlling equipment, vehicle, and personnel movement between facilities limits pathogen transfer. Proper cleaning and disinfection of housing between animal groups reduces environmental contamination.

Nutritional prevention focuses on maintaining immune competence through adequate dietary intake of all essential nutrients. Trace mineral supplementation ensures adequate copper, zinc, selenium, and manganese for optimal immune cell function. Vitamin A and vitamin E support respiratory epithelium integrity and antioxidant defenses. Adequate protein and energy intake maintains body condition and supports immune response capacity. Consistent feed availability avoids nutritional stress that compromises disease resistance. Preconditioning programs that establish calves on feed before marketing improve nutritional status during the high-risk transition period.

Management practices fundamental to Pasteurella pneumonia prevention address stress reduction and environmental quality. Low-stress handling techniques and appropriate facility design minimize physiological stress during processing and routine management. Adequate ventilation in housing removes airborne pathogens and irritants while maintaining appropriate temperature and humidity. Controlling dust through pen surface management and water application reduces respiratory irritation. Appropriate stocking densities provide adequate space while minimizing social stress. Clean, dry bedding maintains a healthy environment and reduces pathogen exposure. Separating age groups and avoiding commingling of cattle from multiple sources limits disease transmission.

Quarantine and testing protocols support respiratory disease prevention through controlled introduction of new animals. Incoming cattle should be observed for at least two to three weeks before mixing with established populations, allowing expression of incubating infections and recovery from transport stress. Health evaluation at arrival identifies animals showing respiratory disease signs for treatment or segregation. Processing protocols including vaccination against respiratory pathogens provide protection during the high-risk adaptation period. Testing for persistent BVDV infection identifies immunosuppressed animals that face elevated respiratory disease risk and can serve as ongoing infection sources.

Daily management and monitoring for respiratory disease prevention requires systematic observation of cattle for early signs of illness. Personnel should be trained to recognize subtle changes in behavior, appetite, and respiratory function that indicate developing disease. Observation routines should assess all animals at least once daily, with more frequent evaluation during high-risk periods. Early case identification enables prompt treatment initiation when antimicrobial therapy is most likely to succeed. Consistent criteria for identifying animals requiring treatment helps ensure appropriate response while avoiding over-treatment of minor conditions.

Housing and environmental management significantly influence respiratory disease risk and should be optimized for cattle health. Buildings should provide adequate ventilation to remove moisture, ammonia, and airborne pathogens while avoiding cold drafts on resting cattle. Recommended ventilation rates vary by animal age, stocking density, and climate but should maintain good air quality without creating chilling drafts. Temperature management including shade provision during heat stress and wind protection during cold weather reduces environmental stress. Dust control through bedding management and pen surface maintenance reduces respiratory irritation. Clean, dry bedding promotes comfort and health.

Herd health programs provide systematic approaches to respiratory disease prevention and management. Veterinary consultation helps develop comprehensive health plans addressing vaccination, parasite control, nutrition, and disease response protocols. Risk assessment identifies operations facing elevated respiratory disease pressure requiring enhanced prevention measures. Standard operating procedures for case identification, treatment, and follow-up ensure consistent appropriate response. Regular program review incorporating health outcome data enables continuous improvement in disease management effectiveness.

Record keeping and monitoring systems generate essential data for respiratory disease management. Individual animal identification enables tracking of disease events, treatments, and outcomes over time. Treatment records must document product, dose, route, date, and withdrawal period for food safety compliance. Morbidity and mortality data should be analyzed regularly to identify trends, evaluate treatment protocols, and compare outcomes to industry benchmarks. Necropsy findings from fatal cases provide valuable diagnostic information and should be recorded systematically. Production records tracking growth performance enable assessment of disease impacts on affected individuals.

Economic considerations influence all aspects of respiratory disease management and should be explicitly evaluated. Prevention program costs including vaccination, facilities, and management investments must be weighed against expected disease reduction benefits. Individual treatment decisions consider drug costs, labor, and expected performance impacts against animal value and recovery probability. Industry analyses consistently demonstrate that prevention investments provide positive returns through reduced treatment costs and performance losses. Operations benefit from tracking their own health economics to inform management decisions and demonstrate program value.

All cattle breeds demonstrate susceptibility to Pasteurella pneumonia, with environmental and management factors exerting greater influence on disease occurrence than breed genetics. British breeds including Angus, Hereford, and their crosses make up the majority of feedlot populations in North America and thus represent a large proportion of respiratory disease cases simply based on population demographics. Continental breeds including Charolais, Limousin, and Simmental face similar risk when subjected to comparable stress and management conditions. No breed demonstrates meaningful resistance to Pasteurella multocida infection.

Production type influences respiratory disease risk patterns more significantly than breed genetics. Feedlot cattle entering commercial feeding operations face elevated risk during the receiving period due to transport stress, commingling, and dietary transitions. Dairy calves, particularly those raised in group housing with multiple sources, experience high respiratory disease pressure during the first months of life. Cow-calf operations typically see lower respiratory disease incidence due to reduced stocking density and stress, though outbreaks can occur following weaning or during weather stress events. Purebred operations with controlled introductions and enhanced management may maintain lower disease pressure than commercial operations with frequent cattle movements.

Genetic selection for respiratory disease resistance has received research attention, though practical implementation remains limited. Studies have identified moderate heritability for susceptibility to bovine respiratory disease, suggesting potential for genetic improvement. Some genetic lines may demonstrate enhanced immune responsiveness or stress resistance that indirectly reduces disease susceptibility. However, current selection programs focus primarily on production and carcass traits, with health traits receiving secondary emphasis. Expected progeny differences (EPDs) for respiratory disease or related traits are not widely available, though industry trends toward including health economics in selection decisions may drive development of genetic tools for improved disease resistance.

Commonly co-occurring conditions with Pasteurella pneumonia include other components of the bovine respiratory disease complex. Viral respiratory infections with IBR, BVDV, BRSV, and PI3 frequently precede bacterial pneumonia, damaging respiratory defenses and creating conditions favorable for Pasteurella proliferation. Co-infection with Mannheimia haemolytica is common during respiratory disease outbreaks, with both organisms isolated from affected animals. Histophilus somni and Mycoplasma bovis may contribute to complex respiratory infections. Multiple pathogen involvement typically results in more severe disease than single-agent infections and complicates treatment decisions.

Conditions with similar symptoms to Pasteurella pneumonia include other causes of bovine respiratory disease requiring differentiation through diagnostic testing. Mannheimia haemolytica pneumonia typically produces more severe acute disease with prominent fibrinous inflammation, though clinical differentiation may be difficult. Mycoplasma bovis causes chronic pneumonia with characteristically poor treatment response. Histophilus somni pneumonia may present with additional systemic manifestations including neurological signs. Aspiration pneumonia follows oral medication errors and affects cranioventral lung regions. Parasitic pneumonia from lungworms produces similar respiratory signs in pastured cattle. Acute interstitial pneumonia or atypical interstitial pneumonia has distinct pathology with pulmonary edema and emphysema.

Complications and sequelae of Pasteurella pneumonia extend beyond the acute respiratory episode. Chronic pneumonia develops in some cases where complete resolution does not occur, resulting in persistent respiratory compromise and reduced performance. Pleural adhesions form when infection extends to pleural surfaces, restricting lung expansion. Secondary bacterial invasion of damaged tissues may lead to abscess formation within consolidated lung regions. Septicemia with spread to other organ systems occurs in severe cases, potentially affecting joints, meninges, or other tissues. Long-term survivors of severe pneumonia often demonstrate chronic ill-thrift with reduced growth rates and impaired feed efficiency throughout their productive life.